FDA.reportPublic FDA data

Augmentin 250 mg / 62.5 MG per 5 ML Oral Suspension

RxCUI
617339
RxNorm name
Augmentin 250 mg / 62.5 MG per 5 ML Oral Suspension
Display name
Augmentin 250 mg / 62.5 MG per 5 ML Oral Suspension
Full name
Augmentin 250 mg / 62.5 MG per 5 ML Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
174cc098-fe49-4f1a-87e2-601c7573f0dbAUGMENTIN 250 MG / 62.5 MG in 5 mL Oral Suspension [PSN] · amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Augmentin] [SBD] · Augmentin (amoxicillin 250 MG / clavulanate 62.5 MG) per 5 ML Oral Suspension [SY] · Augmentin 250 mg / 62.5 MG per 5 ML Oral Suspension [SY]46These highlights do not include all the information needed to use AUGMENTIN safely and effectively. See full prescribing information for AUGMENTIN. AUGMENTIN ® (amoxicillin/clavulanate potassium) Tablets, Powder for Oral Suspension, and Chewable Tablets Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of AUGMENTIN and other antibacterial drugs, AUGMENTIN should be used only to treat infections that are proven or strongly suspected to be caused b20160901